In a study of 796 preoperative gastric cancer patients, 5.4% had synchronous colorectal cancer (SCRC). Endoscopic treatments were successful, and all SCRC patients underwent curative treatment, with no attributed deaths. Cumulative mortality rates showed 12.6% for gastric cancer-related deaths but none for SCRC. Screening total colonoscopy proved effective, suggesting its vital role. Cost-effectiveness analysis revealed a screening cost of 5.86 million yen to prevent one colorectal cancer death compared to non-screened patients.
Journal Article by Koseki Y, Hikage M (…) Bando E et 8 al. in Ann Surg Oncol
© 2023. Society of Surgical Oncology.